L&T Construction won new orders worth Rs2,410 crore from leading developers for the construction of major residential towers in north India
New Delhi: Engineering company Larsen & Toubro (L&T) on Thursday said its construction unit has won Rs2,410 crore new orders across various businesses during April-June 2012, reports PTI.
"L&T Construction, part of the Laresn & Toubro conglomerate has won new orders valued at Rs2,410 crore ... The Buildings and Factories IC (independent company) has secured new orders worth Rs1,921 crore," it said in a statement.
The orders were received from leading developers for the construction of major residential towers across various cities in the northern part of the country, it added.
Besides, the company said, its infrastructure IC has won orders to the tune of Rs345 crore for the design and construction of viaducts and three elevated stations from Delhi Metro Rail Corp which also includes additional orders from various ongoing projects.
"In yet another development, the water effluent and treatment business has received new orders worth Rs244 crore from Bangalore Water Supply and Sewerage Board for upgrading the existing water distribution systems including additional orders from various ongoing projects," the statement said.
L&T is a $12.8 billion technology, engineering, construction, manufacturing and financial services conglomerate with global operations.
Dr Reddy's Lab launched its generic Ropinirole Hydrochloride XR tablets used for treating Parkinson’s disease in the US
New Delhi: Dr Reddy's Laboratories on Thursday said it has launched its generic Ropinirole Hydrochloride XR tablets used for treating Parkinsons disease in the American market after receiving approval from the US health regulator, reports PTI.
The company has launched Ropinirole Hydrochloride XR (extended-release) tablets in the strengths of 2 mg, 4 mg, 6 mg, 8mg, and 12 mg in the US market, Dr Reddy's said in a statement.
The launch follows approval by the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA).
The tablets are bio equivalent generic version of GlaxoSmithKline's Requip XL tablets, it added.
Quoting IMS health, the company said that the Requip XL brand had sales of approximately USD 58 million in the American market for the twelve months ending March 2012.
The Hyderabad based firm's Ropinirole Hydrochloride XR (extended-release) tablets in the strengths of 2 mg, 4 mg and 6 mg are available in 30 and 90 count bottle sizes while 8 mg and 12 mg strengths are available in 30 count bottle sizes.
Scrips of Dr Reddy's Laboratories were today trading at Rs1,618.80 per scrip in the afternoon trade on BSE, up 0.25% from its previous close.
UIDAI have allegedly refused to accept data collected by the Registrar General, which made the home minister to raise the issue at the highest level
New Delhi: Faced with strong protests from Home Minister P Chidambaram, the Union government on Thursday directed the Unique Identification Authority of India (UIDAI) to accept the biometric data collected by Registrar-General of India (RGI) under the Home Ministry (MHA) to give unique ID number to every citizen, reports PTI.
The decision was taken by the Union Cabinet here, a top government source told PTI.
The move came a week after Chidambaram wrote a letter to Prime Minister Manmohan Singh complaining that RGI's National Population Register (NPR) project is "almost at a standstill" due to the refusal of Nandan Nilekani-led UIDAI to accept the NPR data for de-duplication and generation of Aadhaar numbers.
This was for the second time that Chidambaram took up at the highest level the issue of capturing the biometric data of the population by UIADI and its alleged non- cooperation with the RGI project.
The UIDAI comes under the nodal authority of the Planning Commission.
In January last, the Planning Commission and the Home Ministry had been locked in a tussle over the unique identification number project and both of them have taken the issue to the Prime Minister for a solution, which led to a temporary truce under which UIDAI had promised to accept the NPR data.
"Despite directions from the government, the UIDAI is objecting to the conduct of the NPR camps in certain states and is also refusing to accept the biometric data of NPR for de-duplication and generation of Aadhaar numbers," Chidambaram wrote in his latest letter to the Prime Minister.
The Home Minister said he had taken up the issue with UIDAI chairman Nilekani and Home Secretary RK Singh took up the issue with Director General and Mission Director, UIDAI.
"However, despite our best efforts the issues remain unresolved....the MHA is keen to complete the NPR project in two years as announced by the Finance Minister in his Budget speech. This would be possible only if there is complete cooperation from all stakeholders, especially the UIDAI and the state governments," he said.
Government had taken a number of important decisions concerning internal security after the 26/11 Mumbai terror attack. One of these was that the NPR project would be taken up in selected coastal villages on a priority basis and then rolled out in a phased manner in all coastal villages and towns as part of the measures to enforce coastal security.
Subsequently, the government decided to implement this project across the country.
The status of the project as on date is that the coastal NPR project has been completed to a large extent and the data required for the rest of the country has been collected along with Census 2011 and digitization of the same is proceeding at a rapid pace.
"However, regrettably the collection of photographs and biometrics has been facing hurdles at every step on account of the approach of the UIDAI which, it seems, has failed to appreciate the core purpose of NPR," Chidambaram said.
The UIDAI had initially been given the mandate to cover 10 crore population. This was subsequently raised to 20 crore.
When the matter of extending the mandate to covering the entire country had come up, the Home Ministry raised serious concerns about various aspects regarding the unsuitability of the UIDAI data from internal security point of view.
Considering the concerns, the government took a number of important decisions on 27th January this year regarding the implementation of the NPR and UIDAI projects.
The crux of the decision was that as the purpose of UIDAI and NPR are different, the two projects should proceed simultaneously and that each project would accept the biometric data collected by the other, without duplication.